Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Nextrials, Inc. (www.nextrials.com), a leader in clinical research software and services, today announced that its electronic data capture (EDC) and clinical trial data management platform, Prism™, is now integrated with the study design tools offered by Formedix. Formedix's industry leading Origin™ products include database design tools based on the data standards developed by the Clinical Data Interchange Standards Consortium (CDISC), a platform that Nextrials fully supports. In fact, both Nextrials and Formedix are CDISC Registered Solutions Providers. With this strategic partnership, Prism users can now easily build customized databases in just a few mouse clicks, reducing the overall length and cost of clinical trials by expediting study start up through reduced specification and development effort.

“One of Formedix's goals is to build alliances with all of the major electronic data capture (EDC) vendors in the clinical trial industry”

Visitors to the 46th Annual Meeting of the Drug Information Association (DIA), being held June 13-17 at the Walter E. Washington Convention Center in Washington, DC, can view a demonstration of Prism's integration with Formedix at Nextrials' Booth 1320 and at Formedix's Booth 446.

"We are always looking for ways to add features and functionality to Prism, so when our clients asked for the ability to build customized databases in-house, we researched the most effective way to meet this need," said James Rogers, CEO and co-founder of Nextrials. "By partnering with Formedix, we've given users the best in the industry: a powerful but easy-to-use tool to design clinical trial databases that includes the ability to automatically generate annotated electronic case report forms (CRFs), database design specifications and create submission-ready CRFs. The Formedix design toolset also enables companies to establish and use large libraries of CDISC ODM content which can be dragged and dropped from study to study, kick-starting a sponsor's study design."

Eli Lilly and Company recently made its ODM library, containing over 500 forms, 15,000 items and 3,000 codelists, available as free downloads through Formedix for use within the pharmaceutical community.

"One of Formedix's goals is to build alliances with all of the major electronic data capture (EDC) vendors in the clinical trial industry," said Mark Wheeldon, founder and CEO of Formedix. "By partnering with Nextrials, we foster another pipeline to small- to mid-range research organizations that could benefit from our product features, particularly the re-use of libraries of forms, items and codelists for creating databases. We look forward to working with Nextrials' customers."

Nextrials' award-winning Prism melds sophisticated clinical trial management functionality with EDC in a single, integrated package. By receiving a constant flow of data, Prism enables sponsors and sites to fully utilize real-time integration of disparate information and data sources, such as a hospital's EHR or patient records, to better provide a continuum of care for patients enrolled in clinical trials. Prism is the only platform to be successfully used in a multi-site study where real-time, live patient data was collected and shared by what had previously been two disparate data management platforms.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CBD can be used safely in women with advanced breast cancer and clinical anxiety